These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 31201584)

  • 21. Evaluation of the impact of telementoring using ECHO© technology on healthcare professionals' knowledge and self-efficacy in assessing and managing pain for people with advanced dementia nearing the end of life.
    De Witt Jansen B; Brazil K; Passmore P; Buchanan H; Maxwell D; McIlfatrick SJ; Morgan SM; Watson M; Parsons C
    BMC Health Serv Res; 2018 Apr; 18(1):228. PubMed ID: 29606132
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prospective Evaluation of the 21-Gene Recurrence Score Assay for Breast Cancer Decision-Making in Ontario.
    Levine MN; Julian JA; Bedard PL; Eisen A; Trudeau ME; Higgins B; Bordeleau L; Pritchard KI
    J Clin Oncol; 2016 Apr; 34(10):1065-71. PubMed ID: 26598746
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cost effectiveness of gene expression profiling for early stage breast cancer: a decision-analytic model.
    Yang M; Rajan S; Issa AM
    Cancer; 2012 Oct; 118(20):5163-70. PubMed ID: 22359236
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prospective study of the impact of the Prosigna assay on adjuvant clinical decision-making in unselected patients with estrogen receptor positive, human epidermal growth factor receptor negative, node negative early-stage breast cancer.
    Martín M; González-Rivera M; Morales S; de la Haba-Rodriguez J; González-Cortijo L; Manso L; Albanell J; González-Martín A; González S; Arcusa A; de la Cruz-Merino L; Rojo F; Vidal M; Galván P; Aguirre E; Morales C; Ferree S; Pompilio K; Casas M; Caballero R; Goicoechea U; Carrasco E; Michalopoulos S; Hornberger J; Prat A
    Curr Med Res Opin; 2015 Jun; 31(6):1129-37. PubMed ID: 25851308
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Perceptions of Dutch health care professionals on weight gain during chemotherapy in women with breast cancer.
    de Kruif JTCM; Scholtens MB; van der Rijt J; de Boer MR; van den Berg MMGA; de Vries YC; Winkels RM; Visser M; Kampman E; Westerman MJ
    Support Care Cancer; 2019 Feb; 27(2):601-607. PubMed ID: 30022349
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Real-world economic value of a 21-gene assay in early-stage breast cancer.
    Waintraub SE; McNamara D; Graham DMA; Pecora AL; Min J; Wu T; Noh HG; Connors J; Pe Benito R; Choi K; Schultz E; Goldberg SL
    Am J Manag Care; 2017 Dec; 23(12):e416-e420. PubMed ID: 29261249
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Using the 21-gene assay to guide adjuvant chemotherapy decision-making in early-stage breast cancer: a cost-effectiveness evaluation in the German setting.
    Blohmer JU; Rezai M; Kümmel S; Kühn T; Warm M; Friedrichs K; Benkow A; Valentine WJ; Eiermann W
    J Med Econ; 2013; 16(1):30-40. PubMed ID: 22966753
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A Survey Study Evaluating and Comparing the Health Literacy Knowledge and Communication Skills Used by Nurses and Physicians.
    Güner MD; Ekmekci PE
    Inquiry; 2019; 56():46958019865831. PubMed ID: 31342877
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Factors that influence physicians' detection of distress in patients with cancer: can a communication skills training program improve physicians' detection?
    Merckaert I; Libert Y; Delvaux N; Marchal S; Boniver J; Etienne AM; Klastersky J; Reynaert C; Scalliet P; Slachmuylder JL; Razavi D
    Cancer; 2005 Jul; 104(2):411-21. PubMed ID: 15952179
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Women's interest in gene expression analysis for breast cancer recurrence risk.
    O'Neill SC; Brewer NT; Lillie SE; Morrill EF; Dees EC; Carey LA; Rimer BK
    J Clin Oncol; 2007 Oct; 25(29):4628-34. PubMed ID: 17925559
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Health-related quality of life in early breast cancer.
    Groenvold M
    Dan Med Bull; 2010 Sep; 57(9):B4184. PubMed ID: 20816024
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gene expression profile testing for breast cancer and the use of chemotherapy, serious adverse effects, and costs of care.
    Haas JS; Liang SY; Hassett MJ; Shiboski S; Elkin EB; Phillips KA
    Breast Cancer Res Treat; 2011 Nov; 130(2):619-26. PubMed ID: 21681446
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An interprofessional approach to teaching communication skills.
    Sargeant J; MacLeod T; Murray A
    J Contin Educ Health Prof; 2011; 31(4):265-7. PubMed ID: 22189990
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genomics of adjuvant therapy for breast cancer.
    Kim SR; Paik S
    Cancer J; 2011; 17(6):500-4. PubMed ID: 22157294
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Challenges associated with the integration of immuno-oncology agents in clinical practice.
    Lazure P; Parikh AR; Ready NE; Davies MJ; Péloquin S; Caterino JM; Lewandowski R; Lazar AJ; Murray S
    BMC Med Educ; 2022 Nov; 22(1):781. PubMed ID: 36371179
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genomic testing and therapies for breast cancer in clinical practice.
    Haas JS; Phillips KA; Liang SY; Hassett MJ; Keohane C; Elkin EB; Armstrong J; Toscano M
    Am J Manag Care; 2011 May; 17(5 Spec No):e174-81. PubMed ID: 21711068
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Using patient perspectives to inform communication training materials for health care professionals discussing BRCA mutation testing.
    Shilling V; Catt S; Jenkins V; Fallowfield L
    Breast Cancer Res Treat; 2020 Nov; 184(2):491-498. PubMed ID: 32812179
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.
    Williams C; Brunskill S; Altman D; Briggs A; Campbell H; Clarke M; Glanville J; Gray A; Harris A; Johnston K; Lodge M
    Health Technol Assess; 2006 Sep; 10(34):iii-iv, ix-xi, 1-204. PubMed ID: 16959170
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Retention and use of breast cancer recurrence risk information from genomic tests: the role of health literacy.
    Lillie SE; Brewer NT; O'Neill SC; Morrill EF; Dees EC; Carey LA; Rimer BK
    Cancer Epidemiol Biomarkers Prev; 2007 Feb; 16(2):249-55. PubMed ID: 17267389
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.